Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 4,169 | 2,831 | 2,127 | 0 | 0 |
| Cost of Goods | 775 | 489 | 344 | N/A | N/A |
| Gross Profit | 3,394 | 2,342 | 1,783 | N/A | N/A |
| Operating Expenses | 56,184 | 48,238 | 47,067 | 48,542 | 43,001 |
| Operating Income | -52,015 | -45,407 | -44,940 | -48,542 | -43,001 |
| Interest Expense | 4,290 | 1,881 | 1,517 | 1,055 | 945 |
| Other Income | 1,369 | -14,392 | -450 | -1,906 | 255 |
| Pre-tax Income | -54,936 | -61,680 | -46,907 | -51,503 | -43,691 |
| Income Tax | 56 | -3,033 | -253 | -453 | N/A |
| Net Income Continuous | -54,992 | -58,647 | -46,654 | -51,050 | -43,691 |
| Net Income | $-54,992 | $-58,647 | $-46,654 | $-51,050 | $-43,691 |
| EPS Basic Total Ops | -0.39 | -0.41 | -0.33 | -0.40 | -0.35 |
| EPS Basic Continuous Ops | -0.39 | -0.41 | -0.33 | -0.40 | -0.35 |
| EPS Diluted Total Ops | -0.39 | -0.41 | -0.33 | -0.40 | -0.35 |
| EPS Diluted Continuous Ops | -0.39 | -0.41 | -0.33 | -0.40 | -0.35 |
| EBITDA(a) | $-48,789 | $-43,556 | $-42,300 | $-47,775 | $-42,328 |